SCHEMBL8377289

SCHEMBL8377289

CCOC(=O)C(Br)=C(Br)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
HPGD P15428 1/20 0.51
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
PARP10 Q53GL7 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
SRD5A2 P31213 3/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 2/20 0.45
HTT P42858 1/20 0.45
LMNA P02545 1/20 0.45
THRB P10828 1/20 0.45
LTA4H P09960 1/20 0.45
ERCC5 P28715 1/20 0.44
FEN1 P39748 1/20 0.44
MAPK14 Q16539 1/20 0.44
HDAC3 O15379 1/20 0.44
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8377288 1.00 NPC1 (0.51) NPC1RAB9AHPGDCRHBPCRHR2
SCHEMBL11821119 0.88 ALDH1A1 (0.56) NPC1SMN1; SMN2ALDH1A1MAPTLMNA
SCHEMBL1054614 0.88 ALDH1A1 (0.56) NPC1SMN1; SMN2ALDH1A1MAPTLMNA
SCHEMBL4739675 0.81 ALDH1A1 (0.57) NPC1RAB9AHPGDCRHBPCRHR2
SCHEMBL6340266 0.79 ALDH1A1 (0.54) NPC1RAB9AHPGDCRHBPCRHR2
SCHEMBL8375792 0.78 SMN1; SMN2 (0.50) HPGDSMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL8375797 0.78 SMN1; SMN2 (0.50) HPGDSMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL1730420 0.78 SMN1; SMN2 (0.66) NPC1RAB9AHPGDCRHBPCRHR2
SCHEMBL6157109 0.77 SMN1; SMN2 (0.52) NPC1RAB9AHPGDCRHBPCRHR2
SCHEMBL6157660 0.77 SMN1; SMN2 (0.52) NPC1RAB9AHPGDCRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed